PATENT CLAIM ANALYSIS

Application Number: 16174954
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "562000"]

Abstract:
Pharmaceutical compositions are described herein, the compositions consisting essentially of anhydrous suspensions of therapeutically effective quantity of a pharmaceutically acceptable reducing agent capable of undergoing thiol-disulfide exchange with cystine to form a mixed disulfide (such as tiopronin). In some embodiments, the suspension also contains one or more urine alkanizing agent(s). Methods for fabricating the compositions and using them are also described.

Claim (Index 8):
The pharmaceutical composition of  claim 7 , wherein the saturated open-chain acids are selected from the group consisting of caprylic acid and caproic acid.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.31481
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15644286', '14808777', '14808847', '14808809', '14808871']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685050096707723
- 35 USC 102 Novelty (BERT): 0.4914100347003039
- Combined Prediction Score: 0.7407955121737254
- Mean Citation Score: 145.37784000000005
- Max Citation Score: 148.26672
- Similarity Product: 89.96258385904312

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test